Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit

Rhea-AI Summary

Lipella Pharmaceuticals (Nasdaq: LIPO), a clinical-stage biotechnology company, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. CEO Jonathan Kaufman, PhD, will be presenting at the event on Thursday, October 17th, 2024, at 10:30am.

The summit is scheduled to take place from October 15-17, 2024. Interested parties can access the webcast of Lipella's presentation at https://m-vest.com/events/healthcare-10152024. Additionally, Dr. Kaufman will be available for one-on-one meetings with registered investors attending the conference.

Lipella Pharmaceuticals focuses on developing treatments for serious diseases with significant unmet needs, positioning itself as a key player in the biotechnology sector.

PITTSBURGH, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Maxim Healthcare Virtual Summit that is being held on October 15 -17, 2024.

Event: Lipella Presentation - 2024 Maxim Healthcare Virtual Summit

Date: Thursday, October 17^th, 2024

Time: 10:30am

Webcast: https://m-vest.com/events/healthcare-10152024

Jonathan Kaufman will be available for one-on-one meetings with registered investors of the conference.

About Lipella Pharmaceuticals
Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Additionally, Lipella maintains a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists. Lipella completed its initial public offering in December 2022. For more information, please visit www.lipella.com or LinkedIn

CONTACT

Jeff Ramson
PCG Advisory
jramson@pcgadvisory.com
646-863-6893

FAQ

When is Lipella Pharmaceuticals (LIPO) presenting at the 2024 Maxim Healthcare Virtual Summit?

Lipella Pharmaceuticals (LIPO) is presenting at the 2024 Maxim Healthcare Virtual Summit on Thursday, October 17th, 2024, at 10:30am.

Who will be representing Lipella Pharmaceuticals (LIPO) at the 2024 Maxim Healthcare Virtual Summit?

CEO Jonathan Kaufman, PhD, will be representing Lipella Pharmaceuticals (LIPO) at the 2024 Maxim Healthcare Virtual Summit.

How can investors access Lipella Pharmaceuticals' (LIPO) presentation at the 2024 Maxim Healthcare Virtual Summit?

Investors can access Lipella Pharmaceuticals' (LIPO) presentation via webcast at https://m-vest.com/events/healthcare-10152024.

What are the dates for the 2024 Maxim Healthcare Virtual Summit featuring Lipella Pharmaceuticals (LIPO)?

The 2024 Maxim Healthcare Virtual Summit featuring Lipella Pharmaceuticals (LIPO) is being held from October 15 to 17, 2024.

Will Lipella Pharmaceuticals (LIPO) be offering one-on-one meetings at the 2024 Maxim Healthcare Virtual Summit?

Yes, CEO Jonathan Kaufman of Lipella Pharmaceuticals (LIPO) will be available for one-on-one meetings with registered investors at the 2024 Maxim Healthcare Virtual Summit.